Learn more from this KOL roundtable about why CD8+ T cells play a key role in fighting cancer, and why antigen-specificity, quantity and quality matter in developing effective immunotherapies.
Our proprietary, flexible platform can engineer arenaviral therapeutics that mobilize and amplify targeted T cells and antibodies, the body’s natural infection killers, to fight or prevent serious disease.
We work to reprogram the immune system to more effectively combat cancer and infectious diseases. We do this by using a technology that “supercharges” the natural ability of the immune system to combat disease.
The source of HOOKIPA’s strength lies in our people and the skills and experience that they bring.
We want to continue to grow fast as a company and nurture a respectful and diverse culture that encourages teamwork. Attracting and retaining the best people is essential to achieve this. Please get in touch with us to find out more about our career opportunities.
